Transaction · 0001437749-26-032240

Krempa David

Krempa David, CBO, reported a transaction classified as exercise at Eton Pharmaceuticals, Inc. involving 10522.000000 shares for an estimated $0.00. Reported holdings after the transaction were 21044.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCBO
ETONEton Pharmaceuticals, Inc.
Filing timeOct 06
Trade dateOct 02, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$57.68
Pre-filing
1mo ago +7.4%1w ago +0.0%1d ago +0.0%
Returns since
7d30d90d180d1y

ETON price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ETON since 2026-10-06Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001437749-26-032240
Restricted Stock Units
Transaction date
Oct 02, 2026
Filed Oct 06, 2026, 08:49 PM · 4d delay
Shares
10.5k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
21.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Business Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchase…

  2. F2

    The shares were sold in multiple trades at prices ranging from $54.915 to $55.135. The price reported above reflects the weighted average sales price.

  3. F3

    On October 2, 2024, the reporting person was granted 42,088 restricted stock units which vest in four equal annual installments beginning October 2, 2025.

Original filing · 0001437749-26-032240
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ETON